GenSight Biologics S.A. SIGHT
PAR: SIGHT | ISIN: FR0013183985 13/11/2024
0,350 EUR (+14,59%)
(+14,59%)
13/11/2024
Profiel GenSight Biologics S.A.
CEO: Bernard Gilly